Correlation Between Veracyte and Bionano Genomics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Bionano Genomics, you can compare the effects of market volatilities on Veracyte and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Bionano Genomics.
Diversification Opportunities for Veracyte and Bionano Genomics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Veracyte and Bionano is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Veracyte i.e., Veracyte and Bionano Genomics go up and down completely randomly.
Pair Corralation between Veracyte and Bionano Genomics
Given the investment horizon of 90 days Veracyte is expected to under-perform the Bionano Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Veracyte is 5.08 times less risky than Bionano Genomics. The stock trades about -0.01 of its potential returns per unit of risk. The Bionano Genomics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 20.00 in Bionano Genomics on October 22, 2024 and sell it today you would lose (1.00) from holding Bionano Genomics or give up 5.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Bionano Genomics
Performance |
| Timeline |
| Veracyte |
| Bionano Genomics |
Veracyte and Bionano Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Bionano Genomics
The main advantage of trading using opposite Veracyte and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Bionano Genomics vs. Intuitive Surgical | Bionano Genomics vs. Innovative Eyewear | Bionano Genomics vs. Stereotaxis | Bionano Genomics vs. Nexgel Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |